Vanguard Group Inc Biomea Fusion, Inc. Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
A detailed history of Vanguard Group Inc transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,378,064 shares of BMEA stock, worth $2.18 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,378,064
Previous 1,401,113
1.65%
Holding current value
$2.18 Million
Previous $5.44 Million
46.01%
% of portfolio
0.0%
Previous 0.0%
Shares
16 transactions
Others Institutions Holding BMEA
# of Institutions
107Shares Held
15.8MCall Options Held
229KPut Options Held
354K-
Cormorant Asset Management, LP Boston, MA3.57MShares$5.64 Million0.81% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$3.7 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY799KShares$1.26 Million0.59% of portfolio
-
Geode Capital Management, LLC Boston, MA626KShares$989,0050.0% of portfolio
-
State Street Corp Boston, MA597KShares$943,8500.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $46.3M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...